Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis

Hypertension Research

Volumn 30, Issue 7, 2007, Pages 635-642

  Imakiire, Toshihiko ^a   Kikuchi, Yuichi ^a   Yamada, Muneharu ^a   Kushiyama, Taketoshi ^a   Higashi, Keishi ^a   Hyodo, Naomi ^a   Yamamoto, Kojiro ^a   Oda, Takashi ^a   Suzuki, Shigenobu ^a   Miura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin II type 1 receptor blocker; Angiotensin converting enzyme inhibitor; Hypertensive nephrosclerosis; Macrophage; Monocyte chemoattractant protein 1

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD68 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY BIOPSY; MACROPHAGE ACTIVATION; MEMBRANOUS GLOMERULONEPHRITIS; MICROSCOPY; NEPHROSCLEROSIS; NEPHROTIC SYNDROME; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOPSY; CELL MOVEMENT; CHEMOKINE CCL2; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; HYPERTENSION; KIDNEY GLOMERULUS; MACROPHAGES; MIDDLE AGED; NEPHROSCLEROSIS; NEPHROSIS, LIPOID; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES;

EID: 34548039280     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.635     Document Type: Article

References (25)

1. USRDS: United States Renal Data System 2002 Annual Data Report: incidence and prevalence. Am J Kidney Dis 2003; 41 (Suppl 2): S41-S56.
2. Mann JFE, Hilgers KF, Veelken R, Geiger H, Schmieder RE, Luft FC: Effect of antihypertensive therapy on progression of non-diabetic renal disease. Clin Nephrol 1992; 38: S74-S77.
3. Ikee R, Kobayashi S, Saigusa T, et al: Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy. Hypertens Res 2006; 29: 15-22.
4. Johnson RJ, Alpers CE, Yoshimura A, et al: Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464-474.
5. Hilgers KF, Hartner A, Porst M, et al: Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int 2000; 58: 2408-2419.
6. Mezzano S, Droguett A, Burgos ME, et al: Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl 2003; 86: S64-S70.
7. Hilgers KF, Hartner A, Porst M, Veelken R, Mann JFE: Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension. Relation to kidney inflammation. Circulation 2001; 104: 1436-1440.
8. Lewis EJ, Hunsicker LG, Clarke WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
9. Ruggenenti P, Perna A, Gherardi G, et al: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999; 354: 359-364.
10. Hotta O, Yusa N, Ooyama M, Taguma Y: Urinary macrophage counts and ratio to T lymphocytes: possible use in differential diagnosis and management of glomerular disease. J Clin Lab Anal 1996; 10: 205-208.
11. Oda T, Hotta O, Taguma Y, et al: Clinicopathological significance of intratubular giant macrophages in progressive glomerulonephritis. Kidney Int 1998; 53: 1190-1200.
12. Furuta T, Saito T, Ootaka T, et al: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 1993; 21: 480-485.
13. Rodrigues-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ: Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 2004; 286: F606-F616.
14. Arima S, Kohagura K, Abe M, Ito S: Mechanisms that control glomerular hemodynamics. Clin Exp Nephrol 2001; 5: 55-61.
15. Gruden G, Setti G, Hayward A, et al: Mechanical stretch induces monocyte chemoattractant activity via an NF-κB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol 2005; 16: 688-696.
16. Ishimitsu T, Kameda T, Akashiba A, et al: Effects of valsartan on the progression of chronic renal insufficiency in patients with nondiabetic renal diseases. Hypertens Res 2005; 28: 865-870.
17. Agodoa LY, Appel L, Bakris GL, et al, for the African American Study of Kidney Disease and Hypertension (AASK) Group: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001; 285: 2719-2728.
18. Ruggenenti P, Fassi A, Ilieva AP, et al, for the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators: Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351: 1941-1951.
19. Iino Y, Hayashi M, Kawamura T, et al: Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension - a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study. Hypertens Res 2004; 27: 21-30.
20. Prodjosudjadi W, Gerritsma JS, van Es LA, Daha MR, Bruijn JA: Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol 1995; 44: 148-155.
21. Capers Q IV, Alexander RW, Lou P, et al: Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 1997; 30: 1397-1402.
22. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM: Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998; 83: 952-959.
23. Kim S, Ohta K, Hamaguchi A, et al: Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int 1994; 46: 1346-1358.
24. Kagami S, Border WA, Miller DE, et al: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-2437.
25. Rodrigues-Iturbe B, Johnson RJ: Role of inflammatory cells in the kidney in the induction and maintenance of hypertension. Nephrol Dial Transplant 2006; 21: 260-263.